Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : VOLTAIRE'S PORCH-MODERATED -- Ignore unavailable to you. Want to Upgrade?

To: Dealer who wrote (55015)	9/10/2002 6:39:04 PM
From: Dealer	Read Replies (1) \| Respond to of 65232

K-Kellogg USA Issues Allergy Alert on Undeclared Egg, Milk, Soybeans, or Almonds In Kellogg's(R) Cracklin' Oat Bran(R) and Kellogg's(R) Smart Start(R) Cereals Tuesday September 10, 6:32 pm ET BATTLE CREEK, Mich., Sept. 10 /PRNewswire-FirstCall/ -- Kellogg USA of Battle Creek, Mich., is recalling a limited number of Kellogg's® Cracklin' Oat Bran® cereal products because they may contain undeclared egg, milk or soybeans and a limited number of Kellogg's® Smart Start® cereal club store packs because they may contain undeclared almonds and milk. People who have an allergy or severe sensitivity to egg, milk, soybeans or almonds run the risk of serious or life-threatening allergic reaction if they consume these products. ADVERTISEMENT Affected by this recall are 327,400 packages of 17-ounce Kellogg's® Cracklin' Oat Bran® cereal with a UPC code of 38000 04530 and Better If Used Before Dates of JUN 19 2003, JUL 17 2003, JUL 18 2003, or JUL 19 2003 printed on the top of the package. These packages were distributed through retail grocery stores nationwide. Also affected by this recall are 22,176 club store packages of 41.03-ounce Kellogg's® Smart Start® cereal with a UPC code of 38000 71550 and a Better If Used Before Date beginning May 09 2003 KNC printed on the top of the package. These packages were distributed through Costco and BJ's Club Warehouse stores nationwide. No illnesses or allergic reactions have been reported to date in connection with these problems. These recalls were initiated after investigation of consumer complaints revealed that products containing the listed allergens were mixed in with products which do not contain these allergens. Subsequent investigation indicates that the problems were caused by a temporary breakdown in the manufacturing facility production and packaging processes which only affected the specific Better If Used Before dates indicated above. Consumers who have purchased packages of 17-ounce Kellogg's® Cracklin' Oat Bran® cereal with a UPC code of 38000 04530 and Better If Used Before Dates of JUN 19 2003, JUL 17 2003, JUL 18 2003, or JUL 19 2003 or club store packages of 41.03-ounce Kellogg's® Smart Start® cereal with a UPC code of 38000 71550 and a Better If Used Before Date of May 09 2003 KNC can contact Kellogg Consumer Affairs at 800-527-1557 for further information and instructions.

To: Dealer who wrote (55015)	9/10/2002 6:58:51 PM
From: stockman_scott	Respond to of 65232

Federal Investigation of Martha Stewart Sought By Marcy Gordon AP Business Writer Tuesday, September 10, 2002; 3:54 PM Lawmakers asked the Justice Department on Tuesday to begin a criminal investigation into whether Martha Stewart knowingly lied to a House committee examining whether she received inside information before selling her ImClone stock. "As members of Congress we believe it our obligation to forward specific and credible information in our possession that could suggest a federal crime has been committed," members of the House Energy and Commerce Committee said in a letter to Attorney General John Ashcroft. The letter was signed by Republican and Democratic leaders of the panel. Shares of Martha Stewart Omnimedia jumped nearly 10 percent on a surge in volume after the annoucement. The shares were trading up 75 cents at $8.50 in afternoon trading on the New York Stock Exchange. The lawmakers said they have been prevented from resolving discrepancies and "suspicious communications" surrounding the stock sale because Stewart has repeatedly refused to be interviewed by the committee staff and because her attorneys have said she would invoke her Fifth Amendment right if subpoenaed. In the letter, the committee said the investigation of Stewart was warranted because of questions about possible "misbehavior by corporate insiders" and because she is a prominent public figure who heads a publicly traded company. The request for Justice Department action was announced at a news conference by Rep. Billy Tauzin, R-La., chairman of the committee and Rep. Jim Greenwood, R-Pa., chairman of the panel's investigative subcommittee. The letter cites the False Statements Act, which makes it a felony for anyone to "knowingly and willfully make any materially false statement" in an investigation by Congress. The penalty is up to five years in prison and a fine. Earlier Tuesday, a Democratic member of the panel, Rep. Peter Deutsch, D-Fla., said Congress should focus more on the kinds of institutional problems that led to the Enron collapse and stop pursuing the Martha Stewart trading investigation. "My recommendation for the last several weeks was that we process and give the information (on Stewart) to the Justice Department," Deutsch said. "The thing we're not very good at is investigating and prosecuting," the Florida Democrat said on CBS's "The Early Show." He said "our job is to deal with systemic issues in the country," such as preventing such collapses and protecting workers' 401(k) and other pension programs. Deutsch was interviewed on the same day the House panel was to convene to decide where to turn next in its drawn-out investigation of Stewart, whose sale of ImClone stock has drawn heavy scrutiny. Stewart has refused to appear before the committee to answer questions. She sold nearly 4,000 shares of ImClone stock on Dec. 27, a day before the company's application for federal review of Erbitux had been denied. Stewart has steadfastly maintained that she told her Merrill Lynch broker to dispose of the stock if it dropped below $60 per share. The committee has been seeking to clear up discrepancies between her account of the sale and those of her now-suspended broker and his assistant. Lawmakers have been trying to determine whether Stewart, before her stock sale, had information that the FDA was going to reject the drug. The company's stock subsequently plummeted. Questions have remained despite an earlier letter from Stewart's lawyers denying she had received any notice of the FDA's decision, according to the committee. The decision on how to proceed was dividing members of the House panel. "I think the committee, against my recommendation, is going to punt this whole matter over to the Justice Department," Rep. Bart Stupak, D-Mich., predicted Tuesday on NBC's "Today" program. "I think they're going to come up with no conclusion," he said, "and I believe they owe it to Martha Stewart and to the American people to finish this, and I think today we will be abdicating that." Ken Johnson, a committee spokesman, had said last week the panel "reached the end of the road" in trying to get Stewart's cooperation and was considering legal action. He said at the time that possible courses of action included the referral to the Justice Department for potential criminal prosecution. Johnson also said phone records obtained by the committee appear to contradict statements by former ImClone president and Stewart friend Sam Waksal that he did not speak to her or her agents between Dec. 14 and Jan. 5, as well as Stewart's assertion that Waksal did not return a call she made to him during that period. Waksal is the only person who has been charged in the federal investigation of ImClone Systems Inc., which he founded. He pleaded innocent last month to charges of securities fraud, perjury, bank fraud and obstruction of justice. © 2002 The Associated Press